Approximately 85% of patients with acute leukemia undergoing intensive antileukemic treatment develop infections and/or fever during neutropenic phases; in about 50% of these patients clinical, microbiological or clinical and microbiological evidence of infections can be obtained. The response rate is significantly lower in documented infections than in fever of unknown origin (FUO). Evidence-based recommendations for diagnosis and treatment procedures are presented, reflecting study results and expert opinions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00277-003-0766-2 | DOI Listing |
Publication Analysis
Top Keywords
diagnosis treatment
8
documented infections
8
clinical microbiological
8
treatment documented
4
infections
4
infections neutropenic
4
neutropenic patients--recommendations
4
patients--recommendations infectious
4
infectious diseases
4
diseases working
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!